Li Zong

Dr. Li Zong

Changchun Institute of Applied Chemistry, Chinese Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
Li ZongLi Zong
Li Zong
JXJunpeng Xing
Junpeng Xing
SLShu Liu
Shu Liu
ZLZhiqiang Liu
Zhiqiang Liu
FSFengrui Song
Fengrui Song

1 February 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Li ZongLi Zong
Li Zong
GCGuorong Cheng
Guorong Cheng
SLShu Liu
Shu Liu
ZPZifeng Pi
Zifeng Pi
ZLZhiqiang Liu
Zhiqiang Liu
FSFengrui Song
Fengrui Song

20 May 2013 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YSYongping Shi
Yongping Shi
ZSZhigui Su
Zhigui Su
SLSai Li
Sai Li
YCYinan Chen
Yinan Chen
XCXi Chen
Xi Chen
Li ZongLi Zong
Li Zong

14 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Li ZongLi Zong
Li Zong
GCGuorong Cheng
Guorong Cheng
JZJingwu Zhao
Jingwu Zhao
XZXiaoyu Zhuang
Xiaoyu Zhuang
ZZZheng Zhong
Zheng Zhong
FSFengrui Song
Fengrui Song
The cause of death in most breast cancer patients is disease metastasis and the occurrence of multidrug resistance (MDR). Ornithine decarboxylase (ODC), which is involved into multiple pathways, is closely related to carcinogenesis and development. Ursolic acid (UA), a natural triterpenoid compound, has been shown to reverse the MDR characteristics of tumor cells. However, the effect of UA on the invasion and metastasis of tumor cells with MDR is not known. Therefore, we investigated the effects of UA on invasion and metastasis, ODC-related polyamine metabolism, and MAPK-Erk-VEGF/MMP-9 signaling pathways in a doxorubicin-resistant breast cancer cell (MCF-7/ADR) model. The obtained results showed that UA significantly inhibited the adhesion and migration of MCF-7/ADR cells, and had higher affinities with key active cavity residues of ODC compared to the known inhibitor di-fluoro-methyl-ornithine (DFMO). UA could downregulate ODC, phosphorylated Erk (P-Erk), VEGF, and matrix metalloproteinase-9 (MMP-9) activity. Meanwhile, UA significantly reduced the content of metabolites of the polyamine metabolism. Furthermore, UA increased the intracellular accumulation of Dox in MCF-7/ADR cells. Taken together, UA can inhibit against tumor progression during the treatment of breast cancer with Dox, and possibly modulate the Erk-VEGF/MMP-9 signaling pathways and polyamine metabolism by targeting ODC to exert these effects.

5 July 2016 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
RZRuixing Zhang
Ruixing Zhang
XZXiaoyu Zhuang
Xiaoyu Zhuang
Li ZongLi Zong
Li Zong
SLShu Liu
Shu Liu
ZLZhi-Qiang Liu
Zhi-Qiang Liu
FSFengrui Song
Fengrui Song

3 September 2018 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
Li ZongLi Zong
Li Zong
ZPZifeng Pi
Zifeng Pi
SLShu Liu
Shu Liu
JXJunpeng Xing
Junpeng Xing
ZLZhiqiang Liu
Zhiqiang Liu
FSFengrui Song
Fengrui Song